Showing results (1091-1100 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|May 7, 2019
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced MalignanciesShumei Kato, Ryosuke Okamura, Manvita Mareboina, et al.
JCO Precision Oncology|April 30, 2019
Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and SurvivalShumei Kato, Maria C Schwaederlé, Paul T Fanta, et al.
JCO Precision Oncology|October 15, 2021
Adopting Consensus Terms for Testing in Precision MedicineNikki A Martin, Joel E Tepper, Veda N Giri, et al.
JCO Precision Oncology|May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate CancerNicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
JCO Precision Oncology|April 27, 2022
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase InhibitorsMeghan J Price, Vishal Vashistha, David Winski, et al.
JCO Precision Oncology|February 24, 2022
Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid CancersTyler Shugg, Reynold C Ly, Elizabeth J Rowe, et al.
JCO Precision Oncology|February 1, 2022
Addition of Chemotherapy Is Associated With Decreased Survival in Early-Stage (T1-2N0M0) Glottic Squamous Cell Carcinoma Treated With Definitive RadiotherapyChenyang Wang, Amar U Kishan, Ann Raldow, et al.
JCO Precision Oncology|February 1, 2022
Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR StudyFernando Moreno, Javier Gayarre, Sara López-Tarruella, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
JCO Precision Oncology|February 1, 2022
Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTareq Al Baghdadi, Susan Halabi, Elizabeth Garrett-Mayer, et al.
Pageof 140